2.6500
+0.0500
+(1.92%)
At close: April 15 at 4:00:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 206,618 | 9 |
| Sales | 72,658 | 9 |
| Net Shares Purchased (Sold) | 133,960 | 18 |
| Total Insider Shares Held | 1.66M | -- |
| % Net Shares Purchased (Sold) | 8.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SWIRSKY DOUGLAS J Chief Financial Officer | Sale at price 3.18 per share. | Direct | 22,061 | Mar 18, 2025 |
| SANDOVAL DAVID I General Counsel | Sale at price 3.18 per share. | Direct | 1,122 | Mar 18, 2025 |
| SOLEYMANNEZHAD ALI Officer | Sale at price 3.18 per share. | Direct | 3,850 | Mar 18, 2025 |
| SWIRSKY DOUGLAS J Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| SANDOVAL DAVID I General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| SOLEYMANNEZHAD ALI Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 4.64 per share. | Direct | 13,935 | Jan 27, 2025 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.93 per share. | Direct | 8,796 | Jan 27, 2025 |
| SANDOVAL DAVID I General Counsel | Sale at price 4.54 per share. | Direct | 20,272 | Jan 13, 2025 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 4.01 per share. | Direct | 12,021 | Dec 26, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.93 per share. | Direct | 8,796 | Dec 26, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 3.70 - 3.79 per share. | Direct | 11,328 | Dec 9, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 1.64 - 2.93 per share. | Direct | 7,340 | Dec 9, 2024 |
| ERCK STANLEY C Director | Sale at price 3.72 per share. | Direct | 177,403 | Nov 1, 2024 |
| ERCK STANLEY C Director | Conversion of Exercise of derivative security at price 0.04 per share. | Direct | 1,908 | Nov 1, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 3.72 per share. | Direct | 11,166 | Oct 28, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.93 per share. | Direct | 8,778 | Oct 28, 2024 |
| COLLINS CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 14, 2024 |
| ERCK STANLEY C Director | Sale at price 3.71 - 3.78 per share. | Direct | 178,752 | Oct 2, 2024 |
| ERCK STANLEY C Director | Conversion of Exercise of derivative security at price 0.04 per share. | Direct | 1,908 | Oct 2, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 3.82 per share. | Direct | 11,460 | Sep 26, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.93 per share. | Direct | 8,778 | Sep 26, 2024 |
| SOLEYMANNEZHAD ALI Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2024 |
| ERCK STANLEY C Director | Sale at price 3.97 - 4.10 per share. | Direct | 191,655 | Sep 4, 2024 |
| ERCK STANLEY C Director | Conversion of Exercise of derivative security at price 0.04 per share. | Direct | 1,908 | Sep 4, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 4.28 per share. | Direct | 12,840 | Aug 26, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.93 per share. | Direct | 8,778 | Aug 26, 2024 |
| ROSS THOMAS MACKENZIE Officer | Sale at price 4.36 - 4.54 per share. | Direct | 148,135 | Aug 2, 2024 |
| ROSS THOMAS MACKENZIE Officer | Conversion of Exercise of derivative security at price 1.64 per share. | Direct | 54,699 | Aug 2, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 4.75 per share. | Direct | 14,238 | Jul 26, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.93 per share. | Direct | 8,778 | Jul 26, 2024 |
| ROSS THOMAS MACKENZIE Officer | Sale at price 4.03 per share. | Direct | 134,366 | Jul 9, 2024 |
| ROSS THOMAS MACKENZIE Officer | Conversion of Exercise of derivative security at price 1.64 per share. | Direct | 54,699 | Jul 9, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 3.99 per share. | Direct | 39,900 | Jun 27, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 1.64 - 2.93 per share. | Direct | 22,778 | Jun 27, 2024 |
| ROSS THOMAS MACKENZIE Officer | Sale at price 4.09 per share. | Direct | 136,465 | Jun 20, 2024 |
| ROSS THOMAS MACKENZIE Officer | Conversion of Exercise of derivative security at price 1.64 per share. | Direct | 54,699 | Jun 20, 2024 |
| DOUGLAS RICHARD H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| ERCK STANLEY C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| MANDELL ARTHUR M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| BALTHROP PATRICK J SR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| AL-WAKEEL YASIR B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| HEMRAJANI REKHA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| BROOKE WILLIAM W. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| JOHNSTON JOHN JOSEPH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| MASOUD MAHER J.D. Chief Executive Officer | Purchase at price 4.87 - 4.90 per share. | Direct | 489,066 | Jun 10, 2024 |
| JOHNSTON JOHN JOSEPH Director | Sale at price 4.41 per share. | Direct | 22,025 | Mar 26, 2024 |
| JOHNSTON JOHN JOSEPH Director | Conversion of Exercise of derivative security at price 2.14 per share. | Direct | 10,710 | Mar 26, 2024 |
| SWIRSKY DOUGLAS J Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
| ROSS THOMAS MACKENZIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
Related Tickers
CLPT ClearPoint Neuro, Inc.
11.78
+2.08%
CTKB Cytek Biosciences, Inc.
3.7200
-1.06%
RPID Rapid Micro Biosystems, Inc.
2.2800
+2.70%
IART Integra LifeSciences Holdings Corporation
16.08
-3.89%
BRSF Brain Scientific Inc.
0.7500
0.00%
XVIPF Xvivo Perfusion AB (publ)
27.70
0.00%
ANGEN.IS Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.
11.32
+0.09%
PCHM PharmChem, Inc.
2.9800
0.00%
CLS-B.ST Clinical Laserthermia Systems AB (publ)
3.0000
-0.66%
BRKR Bruker Corporation
38.43
-3.85%